Bausch Health
327 hedge funds and large institutions have $2.58B invested in Bausch Health in 2018 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 93 increasing their positions, 115 reducing their positions, and 41 closing their positions.
32% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 41
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
4% more funds holding
Funds holding: 315 → 327 (+12)
2.21% less ownership
Funds ownership: 50.21% → 48% (-2.2%)
19% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 115
29% less capital invested
Capital invested by funds: $3.65B → $2.58B (-$1.07B)
55% less call options, than puts
Call options by funds: $452M | Put options by funds: $1.01B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$60.9M |
| 2 |
Walleye Trading
New York
|
+$56.5M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$55.1M |
| 4 |
GAM
Goldentree Asset Management
New York
|
+$43.6M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$34.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$106M |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$93.9M |
| 3 |
O
OppenheimerFunds
New York
|
-$75.6M |
| 4 |
Morgan Stanley
New York
|
-$58.2M |
| 5 |
Two Sigma Investments
New York
|
-$57.2M |
BHC Hedge Fund Activity: Q1 2018 in Review
327 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2018, worth a combined $2.58B — down 29% from $3.65B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new BHC positions and 41 closed out — a net gain of 13 holders — while 93 added to existing stakes and 115 trimmed.
The largest buyer was Connor, Clark & Lunn Investment Management (CC&L), adding an estimated $60.9M. The largest seller was Renaissance Technologies, cutting an estimated $106M.
- 327 institutional investors held Bausch Health (BHC) as of Q1 2018, up from 315 in Q4 2017.
- Funds reported $2.58B of Bausch Health stock for Q1 2018, down 29% quarter-over-quarter.
- 54 funds opened new Bausch Health positions in Q1 2018 and 41 closed out, a net change of +13 holders.
- The largest Bausch Health buyer in Q1 2018 was Connor, Clark & Lunn Investment Management (CC&L), an estimated $60.9M added.
- The largest Bausch Health seller in Q1 2018 was Renaissance Technologies, an estimated $106M sold.
Based on aggregated 13F filings for Q1 2018.